References
- American Heart Association: Heart Facts. Dallas, American Heart Association, 1988
- Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program, Coordinating Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Bethesda, MD, National Heart, Lung, and Blood Institute, National High Blood Pressure Program, 1993
- American College of Sports Medicine: Physical activity, physical fitness and hypertension, position stand. Med Sci Sports Exerc 1993;25(10):i–x
- Haskell WL: Health consequences of physical activity: understanding and challenges regarding dose-response, JB Wolfe Memorial Lecture. Med Sci Sports Exerc 1994;26(6):649–660
- Jennings GL, Nelson L, Nestel P, et al: The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation 1986;73(1):30–40
- Nelson L, Jennings GL, Esler MD, et al: Effects of changing levels of physical activity on blood-pressure and haemodynamics in essential hypertension. Lancet 1986;2(8505):473–476
- Blumenthal JA, Siegel WC, Appelbaum M: Failure of exercise to reduce blood pressure in patients with mild hypertension: results of a randomized controlled trial. JAMA 1991;266(15):2098–2104
- Gilders RM, Voner C, Dudley GA: Endurance training and blood pressure in normotensive and hypertensive adults. Med Sci Sports Exerc 1989;21(6):629–636.
- Tipton CM, Matthes RD, Marcus KD, et al: Influences of exercise intensity, age, and medication on resting systolic blood pressure of SHR populations. J Appl Physiol 1983;55(4):1305–1310
- Kaplan NM: Treatment of hypertension: drug therapy, in Clinical Hypertension, ed 5. Baltimore, Williams and Wilkins, 1990, pp 182–267
- Tanji JL: Exercise and the hypertensive athlete. Clin Sports Med 1992;11(2):291–302
- Kaplan NM, Alderman MH, Flamenbaum W, et al: Guidelines for the treatment of hypertension. Am J Hypertens 1989;2(2 pt l):75–77
- Lundborg R Astrom H, Bengtsson C, et al: Effect of beta-adrenoceptor blockade on exercise performance and metabolism. Clin Sci 1981;61 (3):299–305
- Gordon NF: Effect of selective and nonselective beta-adrenoceptor blockade on thermoregulation during prolonged exercise in heat. Am J Cardiol 1985;55(10):74D–78D
- Gordon NR Kruger PE, van Rensburg JR et al: Effect of betaadrenoceptor blockade on thermoregulation during prolonged exercise. J Appl Physiol 1985;58 (3):899–906
- Gordon NR van Rensburg JR Russell HM, et al: Effect of beta-adrenoceptor blockade and calcium antagonism, alone and in combination, on thermoregulation during prolonged exercise. Int J Sports Med 1987;8(1):1–5
- Yodfat Y, Fidel J, Bloom DS: Captopril as a replacement for multiple therapy in hypertension: a controlled study. J Hypertension 1985;3(2 suppl):S155–S158
- Hill JE Bulpitt CJ, Fletcher AE: Angiotensin converting enzyme inhibitors and quality of life: the European trial. J Hypertension 1985;3(2 suppl):S91–S94
- Pool PE, Seagren SC, Salel AF: Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension. Am J Cardiol 1985:56(16):86H–91H
- Szlachcic J, Hirsch AT, Tubau JF, et al: Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity. Am J Cardiol 1987;59(5):393–399
- Reaven GM: Role of insulin resistance in human disease, Banting lecture. Diabetes 1988;37(12):1595–1607
- Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149(7):1514–1520
- Kaplan NM, Deveraux RB, Miller HS Jr: Task Force 4: systemic hypertension: 26th Bethesda Conference: Recommendations for Determining Eligibility for Competition in Athletes With Cardiovascular Abnormalities. J Am Coll Cardiol 1994;24(4):885–888